Paid Clinical Trials in Texas

Texas has 5,347 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

for Acute Promyelocytic Leukemia With PML-RARA

Sites in Houston, Sugar Land +3 more locations

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 10+

Code: NCT01409161·Phase 2·Recruiting·Listed Aug 2011

Apply to this trial

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

for Acute Biphenotypic Leukemia

Drug: Venetoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 65

Code: NCT02115295·Phase 2·Recruiting·Listed Apr 2014

Apply to this trial

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

for Blood And Marrow Transplantation

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: All ages

Code: NCT02438904·Recruiting·Listed May 2015

Apply to this trial

Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

for Brain Neoplasm

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT02754544·Recruiting·Listed Apr 2016

Apply to this trial

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

for B Acute Lymphoblastic Leukemia

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 14+

Code: NCT02877303·Phase 2·Recruiting·Listed Aug 2016

Apply to this trial

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

for Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03263572·Phase 2·Recruiting·Listed Aug 2017

Apply to this trial

Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization

for Cancer-related Venous Thromboembolism

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03407469·Recruiting·Listed Jan 2018

Apply to this trial

Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer

for Rectal Adenocarcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03594630·EARLY_Phase 1·Recruiting·Listed Jul 2018

Apply to this trial

Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia

for Recurrent Acute Myeloid Leukemia

Drug: Venetoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03629171·Phase 2·Recruiting·Listed Aug 2018

Apply to this trial

LET Optimized IMPT in Treating Pediatric Patients With Ependymoma

for Anaplastic Ependymoma

Sites in Houston +1 more location

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: Up to 22

Code: NCT03750513·Phase 1·Recruiting·Listed Nov 2018

Apply to this trial

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

for Blasts 10-19 Percent of Bone Marrow Nucleated Cells

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03896269·Phase 1·Recruiting·Listed Mar 2019

Apply to this trial

Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

for Stage II Vulvar Cancer AJCC v8

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04169763·Phase 1·Recruiting·Listed Nov 2019

Apply to this trial

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

for Chronic Myelomonocytic Leukemia

Drug: Canakinumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04239157·Phase 2·Recruiting·Listed Jan 2020

Apply to this trial

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

for Ankylosing Spondylitis

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04751396·Recruiting·Listed Feb 2021

Apply to this trial

Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

for Acute Myeloid Leukemia

Drug: Venetoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT04774393·Phase 1, Phase 2·Recruiting·Listed Mar 2021

Apply to this trial

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

for Central Nervous System Lymphoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05011045·Recruiting·Listed Aug 2021

Apply to this trial

Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas

for Pelvic Sarcoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05054335·Recruiting·Listed Sep 2021

Apply to this trial

A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain

for Brain Tumor

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05342454·Recruiting·Listed Apr 2022

Apply to this trial

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

for Hodgkin Lymphoma

Drug: Mosunetuzumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05615636·Phase 2·Recruiting·Listed Nov 2022

Apply to this trial

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

for Refractory Solid Tumors

Drug: Irinotecan

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 1 - 25

Code: NCT06006273·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid Lobectomy

for Thyroid Lobectomy

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06085625·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

for Pneumococcal Vaccine

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06181656·Recruiting·Listed Dec 2023

Apply to this trial

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

for Obstetrical Complications

Sites in Houston +13 more locations

Sponsor: The George Washington University Biostatistics Center

Sex: Female·Age: All ages·Accepts healthy volunteers

Code: NCT06605118·Phase 3·Recruiting·Listed Sep 2024

Apply to this trial

Stepped Care Treatment for Anxiety Resilience

for Generalized Anxiety Disorder (GAD)

1 location in Houston

Sponsor: Andrew Wiese

Sex: All·Age: 7 - 17

Code: NCT07228143·Recruiting·Listed Nov 2025

Apply to this trial

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

for Esophageal Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06414902·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

for Chemotherapy-induced Peripheral Neuropathy

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06389721·Recruiting·Listed Apr 2024

Apply to this trial

An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

for Brain Mass

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT01668082·Recruiting·Listed Aug 2012

Apply to this trial

Single Versus Dual Implant Fixation of Distal Femur Fractures

for Articular Fractures

Sites in Galveston +15 more locations

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT06286670·Recruiting·Listed Feb 2024

Apply to this trial

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

for Human Papillomavirus

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 21+

Code: NCT06434337·Recruiting·Listed May 2024

Apply to this trial

A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma

for Hodgkin's Lymphoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 1+·Accepts healthy volunteers

Code: NCT05355051·Phase 2·Recruiting·Listed May 2022

Apply to this trial

A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma

for Appendiceal Adenocarcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT05947838·Recruiting·Listed Jul 2023

Apply to this trial

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

for Ovarian Cancer

Drug: Bevacizumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT06083844·Phase 2·Recruiting·Listed Oct 2023

Apply to this trial

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

for Endometrial Cancer

Sites in Houston, Katy +18 more locations

Sponsor: Mayo Clinic

Sex: Female·Age: 18+

Code: NCT05051722·Recruiting·Listed Sep 2021

Apply to this trial

Comparison of Uncomplicated Candidemia Therapy Duration in Children

for Invasive Candidiasis

Sites in Dallas, Austin +19 more locations

Sponsor: Arkansas Children's Hospital Research Institute

Sex: All·Age: 120 Days+

Code: NCT05763251·Recruiting·Listed Mar 2023

Apply to this trial

Analysis of Coronary Reactivity Testing With and Without Intracoronary Nitrate Testing

for ANOCA - Angina With Non-obstructive Coronary Arteries

1 location in Plano

Sponsor: Baylor Research Institute

Sex: All·Age: 18+

Code: NCT06896903·Recruiting·Listed Mar 2025

Apply to this trial

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

for Breast Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 60+

Code: NCT06897488·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors

for Post-stroke Depression

1 location in Houston

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 55+

Code: NCT06864715·Recruiting·Listed Mar 2025

Apply to this trial

Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness

for Persian Gulf Syndrome

Sites in Dallas +9 more locations

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT06716411·Recruiting·Listed Dec 2024

Apply to this trial

Study of Patients Being Treated With Anti-obesity Medication

for Obesity and Overweight

1 location in Lubbock

Sponsor: Texas Tech University

Sex: All·Age: 18+

Code: NCT06790160·Recruiting·Listed Jan 2025

Apply to this trial

Pilot Testing a Novel Approach to Pediatric Obesity Treatment

for Overweight Adolescents

1 location in Lubbock

Sponsor: Texas Tech University

Sex: All·Age: 11 - 14

Code: NCT06755827·Phase 1, Phase 2·Recruiting·Listed Jan 2025

Apply to this trial